REGULATED PRESS RELEASE published on 10/30/2023 at 06:00, 2 years 9 months ago Biophytis and Innovation Solutions Pharma sign a partnership agreement to accelerate market access for Sarconeos (BIO101) in Brazil
PRESS RELEASE published on 10/27/2023 at 23:00, 2 years 9 months ago Biophytis receives notice of delisting from Nasdaq and announces it will request a hearing before the Nasdaq Hearings Panel
REGULATED PRESS RELEASE published on 10/27/2023 at 23:00, 2 years 9 months ago Biophytis receives notice of delisting from Nasdaq and announces it will request a hearing before the Nasdaq Hearings Panel
REGULATED PRESS RELEASE published on 10/23/2023 at 07:00, 2 years 9 months ago Biophytis announces the launch of a rights issue with maintenance of shareholders’ preferential subscription rights to continue the execution of its strategic roadmap
PRESS RELEASE published on 09/27/2023 at 23:15, 2 years 10 months ago Biophytis releases its half-yearly accounts as of 30 June 2023 and provides an update on its operations
PRESS RELEASE published on 09/25/2023 at 07:06, 2 years 10 months ago Biophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)
PRESS RELEASE published on 09/19/2023 at 07:00, 2 years 10 months ago Biophytis provides an update on its early access programs for Sarconeos (BIO101) in the treatment of severe forms of COVID-19
PRESS RELEASE published on 09/14/2023 at 07:00, 2 years 10 months ago Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer
PRESS RELEASE published on 09/11/2023 at 07:00, 2 years 10 months ago Biophytis obtains FDA Authorization to initiate the SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 09/04/2023 at 23:00, 2 years 11 months ago Biophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New York
Published on 08/06/2026 at 23:15, 1 hour 17 minutes ago LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 2 hours 17 minutes ago Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/06/2026 at 22:05, 2 hours 27 minutes ago Innodata Reports Record Second Quarter 2026 Results
Published on 08/06/2026 at 22:00, 2 hours 32 minutes ago Gold Terra Announces Closing of Second Tranche of the C$10.8M LIFE
Published on 08/06/2026 at 15:00, 9 hours 32 minutes ago Norsemont Strategically Expands Choquelimpie Land Package To 9,048 Hectares
Published on 08/06/2026 at 22:15, 2 hours 17 minutes ago BIRKENSTOCK SEEKS TO FILL VACANCY IN THE BOARD OF DIRECTORS WITH AN INDEPENDENT DIRECTOR, FOLLOWING ALEXANDRE ARNAULT'S RESIGNATION DUE TO PROFESSIONAL COMMITTMENTS
Published on 08/06/2026 at 21:45, 2 hours 47 minutes ago FP Markets Analysis: Japanese Yen at a Crossroads as Markets Weigh Next Move
Published on 08/06/2026 at 19:05, 5 hours 27 minutes ago Cision Wins 2026 MarTech Breakthrough Awards for Social Listening, Press Release Distribution, and AEO
Published on 08/06/2026 at 18:24, 6 hours 8 minutes ago EQS-Adhoc: Allgeier SE: Allgeier Increases Revenue by 10 Percent in the First Half of 2026 and Confirms Its Guidance for 2026
Published on 08/06/2026 at 18:26, 6 hours 6 minutes ago Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 17:45, 6 hours 47 minutes ago Declaration of voting rights at the end of July 2026
Published on 08/06/2026 at 17:35, 6 hours 57 minutes ago Groupe des Assurances du Crédit Mutuel (GACM)’s Solvency II ratio was 227% as of June 30, 2026
Published on 08/06/2026 at 17:35, 6 hours 57 minutes ago Availability of the financial statements of Groupe des Assurances du Crédit Mutuel for the first half of 2026
